197 related articles for article (PubMed ID: 16696473)
21. Determination of the prescription dose for biradionuclide permanent prostate brachytherapy.
Nuttens VE; Lucas S
Med Phys; 2008 Dec; 35(12):5451-62. PubMed ID: 19175105
[TBL] [Abstract][Full Text] [Related]
22. A spreadsheet technique for dosimetry of transperineal prostate implants.
Feygelman V; Noriega BK; Sanders RM; Friedland JL
Med Phys; 1995 Jan; 22(1):97-100. PubMed ID: 7715574
[TBL] [Abstract][Full Text] [Related]
23. Effect of planning margin on dosimetric quality in 131Cs permanent prostate brachytherapy.
Li T; Fountain BL; Duffy EW
Brachytherapy; 2010; 9(2):159-64. PubMed ID: 19853535
[TBL] [Abstract][Full Text] [Related]
24. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
Chen Z; Bongiorni P; Nath R
Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
26. Modeling the impact of prostate edema on LDR brachytherapy: a Monte Carlo dosimetry study based on a 3D biphasic finite element biomechanical model.
Mountris KA; Bert J; Noailly J; Aguilera AR; Valeri A; Pradier O; Schick U; Promayon E; Ballester MA; Troccaz J; Visvikis D
Phys Med Biol; 2017 Mar; 62(6):2087-2102. PubMed ID: 28140369
[TBL] [Abstract][Full Text] [Related]
27. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
Nath S; Chen Z; Yue N; Trumpore S; Peschel R
Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
[TBL] [Abstract][Full Text] [Related]
29. Edema and Seed Displacements Affect Intraoperative Permanent Prostate Brachytherapy Dosimetry.
Westendorp H; Nuver TT; Hoekstra CJ; Moerland MA; Minken AW
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):197-205. PubMed ID: 27325474
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the dose distribution for prostate implants using various 125I and 103Pd sources.
Meigooni AS; Luerman CM; Sowards KT
Med Phys; 2009 Apr; 36(4):1452-8. PubMed ID: 19472652
[TBL] [Abstract][Full Text] [Related]
31. Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
Waterman FM; Yue N; Corn BW; Dicker AP
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1069-77. PubMed ID: 9719117
[TBL] [Abstract][Full Text] [Related]
32. The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers.
Chen ZJ; Roberts K; Decker R; Pathare P; Rockwell S; Nath R
Phys Med Biol; 2011 Aug; 56(15):4895-912. PubMed ID: 21772076
[TBL] [Abstract][Full Text] [Related]
33. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film.
Chiu-Tsao ST; Napoli JJ; Davis SD; Hanley J; Rivard MJ
Appl Radiat Isot; 2014 Sep; 92():102-14. PubMed ID: 25038559
[TBL] [Abstract][Full Text] [Related]
34. Multiple-estimate monte carlo calculation of the dose rate constant for a cesium-131 interstitial brachytherapy seed.
Wittman RS; Fisher DR
Med Phys; 2007 Jan; 34(1):49-54. PubMed ID: 17278489
[TBL] [Abstract][Full Text] [Related]
35. A systematic study of imaging uncertainties and their impact on 125I prostate brachytherapy dose evaluation.
Lindsay PE; Van Dyk J; Battista JJ
Med Phys; 2003 Jul; 30(7):1897-908. PubMed ID: 12906208
[TBL] [Abstract][Full Text] [Related]
36. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
37. Which patients benefit from post-implant CT dosimetry after real-time intraoperative planning for low dose rate prostate brachytherapy? Case series and systematic literature review.
Mitina N; Christie D; Hill B; Middlebrook N; Nadezhdin N
J Med Imaging Radiat Oncol; 2016 Apr; 60(2):260-7. PubMed ID: 26568444
[TBL] [Abstract][Full Text] [Related]
38. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
Bohm TD; DeLuca PM; DeWerd LA
Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
[TBL] [Abstract][Full Text] [Related]
39. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
40. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
